Applications of recombinant Leishmania amazonensis expressing egfp or the beta-galactosidase gene for drug screening and histopathological analysis.
about
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous LeishmaniasisAppraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasisStage-regulated GFP Expression in Trypanosoma cruzi: applications from host-parasite interactions to drug screeningDevelopment and validation of four Leishmania species constitutively expressing GFP protein. A model for drug discovery and disease pathogenesis studies.Efficacy of Recombinant Canine Distemper Virus Expressing Leishmania Antigen against Leishmania Challenge in DogsReal-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery.An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein.Visceral leishmaniasis: experimental models for drug discovery.Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes.Leishmania amastigotes as targets for drug screening.Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cellsLeishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.A non-commercial approach for the generation of transgenic Leishmania tarentolae and its application in antileishmanial drug discovery.Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein.Identification of Renieramycin A as an Antileishmanial Substance in a Marine Sponge Neopetrosia sp.Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasisIdentification of Renieramycin A as an Antileishmanial Substance in a Marine Sponge Neopetrosia sp
P2860
Q26786195-C7B769DE-89C7-4AB5-BF0D-FD1CEC1537AFQ28485377-4F9A3380-5E38-4191-9958-C15A9EDF18E7Q28534035-01615C2A-4974-4A3D-B811-F650D7B9E768Q35047048-871D1F88-B1AA-42D4-A8B0-7F8922EE5422Q35688323-23A44193-8D7A-4D8B-A36C-535C85B4581AQ36994297-2710E79B-828F-43D3-A288-967CB436BBACQ37069597-8C9999D3-23F8-49C4-A76A-2D23B382EED3Q37842069-8C09156B-65F8-4D73-93E0-64E87B3B8FA7Q39067203-459D7E3B-63D2-4EDA-8317-A6651768E2C8Q39085580-EFBD634C-5678-4251-B050-68E3D444F55FQ39548200-3E688CC9-C20C-41CA-A45B-918102655B93Q40276020-B54F5EBC-7B3A-4451-8EC1-13D9ED26FFE9Q40676578-0BA54325-A940-4545-B7BF-8DFA4A33CA52Q41125410-60D3DF90-E8E4-42F7-A9AE-B97745F42E99Q50281588-AA83C3A4-1D91-454D-BDCC-AF8F12E2D905Q57190987-40C3E929-DF37-4FE5-9C4E-B10F1332B23EQ58867749-24C1FF56-548E-46FB-83CE-3BC89E3E6B7F
P2860
Applications of recombinant Leishmania amazonensis expressing egfp or the beta-galactosidase gene for drug screening and histopathological analysis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Applications of recombinant Le ...... nd histopathological analysis.
@en
Applications of recombinant Le ...... nd histopathological analysis.
@nl
type
label
Applications of recombinant Le ...... nd histopathological analysis.
@en
Applications of recombinant Le ...... nd histopathological analysis.
@nl
prefLabel
Applications of recombinant Le ...... nd histopathological analysis.
@en
Applications of recombinant Le ...... nd histopathological analysis.
@nl
P2093
P356
P1433
P1476
Applications of recombinant Le ...... nd histopathological analysis.
@en
P2093
Haruki Otsuka
Takahiro Okuno
Yasunobu Matsumoto
Yoshitsugu Matsumoto
P304
P356
10.1538/EXPANIM.52.109
P577
2003-04-01T00:00:00Z